Title :

Myeloablative and reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation in myelofibrosis: a retrospective study by the chronic malignancies working party of ebmt

Author(s) :

Mclornan, Donal [Auteur]
Szydlo, Richard [Auteur]
Koster, Linda [Auteur]
Chalandon, Yves [Auteur]
Robin, Marie [Auteur]
Wolschke, Christine [Auteur]
Beelen, Dietrich [Auteur]
Socie, Gerard [Auteur]
Bornhauser, Martin [Auteur]
Angelucci, Emanuele [Auteur]
Niederwieser, Dietger [Auteur]
Gerbitz, Arnim [Auteur]
Finke, Jurgen [Auteur]
Vitek, Antonin [Auteur]
Itala-Remes, Maija [Auteur]
Radujkovic, Aleksandar [Auteur]
Kanz, Lothar [Auteur]
Potter, Victoria [Auteur]
Chevallier, Patrice [Auteur]
Stelljes, Matthias [Auteur]
Petersen, Eefke [Auteur]
Robinson, Stephen [Auteur]
Poire, Xavier [Auteur]
Klyuchnikov, Evgeny [Auteur]
Hernandez-Boluda, Juan Carlos [Auteur]
Czerw, Tomasz [Auteur]
Hayden, Patrick [Auteur]
Kroger, Nicolaus [Auteur]
Yakoub-Agha, Ibrahim [Auteur]
Lille Inflammation Research International Center - U 995 [LIRIC]

Journal title :

Biology of Blood and Marrow Transplantation

Abbreviated title :

Biol. Blood Marrow Transplant.

Volume number :

25

Pages :

2167-2171

Publication date :

2019-11

ISSN :

1523-6536

English keyword(s) :

Reduced intensity
Myeloproliferative
Stem cell transplantation
Myeloablative

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

This retrospective study by the European Society for Blood and Marrow Transplantation analyzed the outcome of 2224 patients with myelofibrosis (MF) who underwent allogeneic stem cell transplantation (allo-SCT) between 2000 ...
Show more >This retrospective study by the European Society for Blood and Marrow Transplantation analyzed the outcome of 2224 patients with myelofibrosis (MF) who underwent allogeneic stem cell transplantation (allo-SCT) between 2000 and 2014; 781 (35%) underwent myeloablative conditioning (MAC) and 1443 (65%) reduced-intensity conditioning (RIC). Median patient age was 52.9 years (range, 18 to 74 years) and 57.5 years (range, 21 to 76 years) in the MAC and RIC cohorts, respectively. Donor type was similar: matched sibling donors (MAC, 317 [41%]; RIC, 552 [38%]) and unrelated donors (MAC, 464 [59%]; RIC, 891 [62%]). Median time to both neutrophil and platelet (>20 × 109Show less >

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Collections :

• Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Submission date :

2024-01-30T10:28:06Z
2024-01-31T13:01:09Z